期刊文献+

药物基因组转化医学教育策略 被引量:2

The educational strategies for pharmacogenomics Translational Medicine
下载PDF
导出
摘要 药物基因组转化医学的主要目的是根据药物基因组学知识的发展让患者获得最佳的治疗方式、最合适的药物种类和药物剂量。通过分析我国医学生教育体系存在的主要问题和目前药物基因组转化医学知识普及的迫切需要,我们总结了国内外的教学经验,对医学生开展药物基因组转化医学教学策略进行了初步探讨。 The main purpose of pharmacog- enomics translational medicine is that enable ev- ery patient receives the most appropriate medical treatment and the most suitable dosage and drug combination. After finding out the main prob- lems of our medical education system and reali- zing the urgent situation of spreading the educa- tion of pharmacogenomics translational medi-cine, we summarize the education experience of domestic and foreign medical school in order to obtain more scientific education strategies.
作者 罗芝英 张伟
出处 《中国临床药理学与治疗学》 CAS CSCD 2012年第5期588-592,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金(30801421) 863计划(2012AA02A518 2009AA022710 2009AA022703) 湖南省科技计划(11K073 10JJ4020) 新世纪优秀人才资助计划(NCET-10-0843)
关键词 药物基因组学 转化医学 个体化医疗 教育策略 Pharmacogenomics Translational medicine Personalized medicine Educa-tion strategies
  • 相关文献

参考文献19

  • 1Dubey AK, Palaian PS, Shankar PR. Pharmacog- enomics-a new approach towards personalized medi- cine[J]. J Pak Med Assoc,2006,56(9) z426.
  • 2Evans JP, Meslin EM, Marteau TM, et al. Ge- nomics. Deflating the genomic bubble[J]. Science, 2011,331(6019) :861-862.
  • 3吕锦晶,王东根,徐天昊.转化医学与肿瘤研究现状[J].中华医学科研管理杂志,2011,24(3):216-216. 被引量:3
  • 4Flordellis CS. The emergence of a new paradigm of pharmacogenomics[J]. Pharmacogenomics,2005, 6 (5) :515-526.
  • 5Yuen MF, Lai CL. Serological markers of liver cancer[J]. Best Pract Res Clin Gastroenterol, 2005,19(1) :91-99.
  • 6Evans WE, Mcleod HL. Pharmacogenomics drug disposition, drug targets, and side effects[J]. N Engl J Med, 2003,348(6) :538-549.
  • 7李金恒.临床个体化用药中的药物基因组学考虑[J].中国临床药理学与治疗学,2007,12(4):361-365. 被引量:17
  • 8张伟,周宏灏.药物基因组学和个体化医学的转化研究进展[J].药学学报,2011,46(1):1-5. 被引量:19
  • 9Higgs JE, Andrews J, Gurwitz D, et al. Pharma- cogenetics education in British medical schools[J]. Genomic Med,2008,2(3/4):101 105.
  • 10Hamburg MA, Collins FS. The path to personal- izedmedicine[J]. N EnglJ Med, 2010,363(4):301 -304.

二级参考文献62

共引文献247

同被引文献51

  • 1杜冠华,何国荣,成银霞.世界药理学研究现状与进展——第15届世界药理学大会概述[J].中国医药导刊,2006,8(5):313-317. 被引量:3
  • 2许力,王升启.药物基因组学的发展及其在个体化用药中的应用[J].国外医学(药学分册),2006,33(6):441-444. 被引量:22
  • 3Casey LO, Emily BD, Peter TH, et al. Deriving rules and as- sertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions[J]. J Am Med Inform Assoc, 2012, 19:840-850.
  • 4Parikh KS, Ahmad T, Fiuzat M. Potential applications of pharmacogenomics to heart failure therapies[J]. Heart Fail Clin, 2014, 10(4):599-606.
  • 5Padulles A, Rama I, Llaud6 I, et al. Developments in renal pharmacogenomics and applications in chronic kidney dis- ease[J]. Pharmgenomics Pers Med, 2014, 28(7):251-266.
  • 6Kohler JR, Guennel T, Marshall SL. Analytical strategies for discovery and replication of genetic effects in pharmacoge- nomic studies[J]. Pharmgenomics Pers Med, 2014, 13(7): 217-225.
  • 7Cacabelos R. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics[J]. Drug Dev Res, 2014,75(6):348-365.
  • 8杨锐.为患者提供个体化的“基因处方”[J].中国医药报,2013,6:7.
  • 9Katara P. Single nucleotide polymorphism and its dynamics for pharmacogenomics[J]. Interdiscip Sci, 2014, 6(2):85-92.
  • 10Blankstein S. Pharmacogenomics: history, barriers, and regu- latory solutions[J]. Food Drug Law J, 2014, 69(2):273-314.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部